Advertisement
Advertisement

ADCT

ADCT logo

ADC Therapeutics SA

3.48
USD
Sponsored
+0.05
+1.46%
May 13, 16:00 UTC -4
Closed
exchange

Pre-Market

3.55

+0.07
+2.01%

ADC Therapeutics SA Profile

About

ADC Therapeutics SA is a late clinical-stage oncology-focused biotechnology company. It engages in development and commercialization of antibody drug conjugates for patients suffering from hematological malignancies and solid tumors. ADC Therapeutics SA is based in LAUSANNE, Switzerland.

Info & Links

CEO

Ameet Mallik

Headquarters

BIOPOLE,ROUTE DE LA CORNICHE 3B
EPALINGES, V8 1066, SWITZERLAND

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.adctherapeutics.com

Auditor

PricewaterhouseCoopers SA

Share holders

182

Employees

193

ADC Therapeutics SA Statistics

Valuation Measures

Market Capitalization2

451.53M

Enterprise Value

305.64M

Enterprise Value/EBITDA(ttm)

-2.56

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

5.87

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

92.98%

Operating Margin(ttm)

-175.30%

Profit Margin(ttm)

-186.36%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

139.95%

Return on Assets(ttm)

-47.26%

Income Statement

Revenue(ttm)

81.36M

Revenue Per Share(ttm)

0.64

Gross Profit(ttm)

75.56M

EBITDA(ttm)3

-119.62M

Net Income Available to Common(ttm)

-142.62M

Diluted EPS(ttm)

-1.20

Share Statistics

Beta (5Y Monthly)

1.94

52-Week Change

163.64%

S&P 500 52-Week Change

26.33%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

127.04M

Dividend Yield

0.00%

Float4

120.18M

% Held by Insiders

5.40%

% Held by Institutions

41.10%

Balance Sheet

Total Cash(mrq)

261.34M

Total Cash Per Share(mrq)

2.06

Total Debt(mrq)

115.45M

Total Debt/Equity(mrq)

-62.13%

Current Ratio(mrq)

4.37%

Quick Ratio(mrq)

4.31%

Book Value Per Share(mrq)

-1.48

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.11

Free Cash Flow(ytd)

-140.78M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement